Synthesis of group A streptococcal virulence factors is controlled by a regulatory RNA molecule

M. Mangold, M. Siller, B. Roppenser, B.J.M. Vlaminckx, T.A. Penfound, R. Klein, R. Novak, R.P. Novick, Emmanuelle Charpentier

Publikation: Beitrag in FachzeitschriftArtikelBegutachtung

Abstract

The capacity of pathogens to cause disease depends strictly on the regulated expression of their virulence factors. In this study, we demonstrate that the untranslated mRNA of the recently described streptococcal pleiotropic effect locus (pel), which incidentally contains sagA, the structural gene for streptolysin S, is an effector of virulence factor expression in group A beta-haemolytic streptococci (GAS). Our data suggest that the regulation by pel RNA occurs at both transcriptional (e.g. emm, sic, nga) and post-transcriptional (e.g. SpeB) levels. We could exclude the possibility that the pel phenotype was linked to a polar effect on downstream genes (sagB-I). Remarkably, the RNA effector is regulated in a growth phase-dependent fashion and we provide evidence that pel RNA expression is induced by conditioned media.
OriginalspracheEnglisch
Seiten (von - bis)1515-1527
Seitenumfang13
FachzeitschriftMolecular Microbiology
Jahrgang53
Ausgabenummer5
DOIs
PublikationsstatusVeröffentlicht - 3 Aug. 2004
Extern publiziertJa

Forschungsfelder

  • Virologie und RNA Biologie

IMC Forschungsschwerpunkte

  • Medical biotechnology

ÖFOS 2012 - Österreichischen Systematik der Wissenschaftszweige

  • 304005 Medizinische Biotechnologie

Dieses zitieren